A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
Titel:
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
Auteur:
Mohammad, Helai P. Smitheman, Kimberly N. Kamat, Chandrashekhar D. Soong, David Federowicz, Kelly E. Van Aller, Glenn S. Schneck, Jess L. Carson, Jeffrey D. Liu, Yan Butticello, Michael Bonnette, William G. Gorman, Shelby A. Degenhardt, Yan Bai, Yuchen McCabe, Michael T. Pappalardi, Melissa B. Kasparec, Jiri Tian, Xinrong McNulty, Kenneth C. Rouse, Meagan McDevitt, Patrick Ho, Thau Crouthamel, Michelle Hart, Timothy K. Concha, Nestor O. McHugh, Charles F. Miller, William H. Dhanak, Dashyant Tummino, Peter J. Carpenter, Christopher L. Johnson, Neil W. Hann, Christine L. Kruger, Ryan G.